EMvision Medical Devices (ASX:EMV) Beginning Cash Position: A$10.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:EMV EMvision Medical Devices Ltd ASX:EMV
24 GF Score
Price A$1.70
! 3 Warning Signs
View Full Analysis

What is EMvision Medical Devices Beginning Cash Position?

EMvision Medical Devices ASX:EMV -3.69% 24 Beginning Cash Position is A$10.46 Mil as of Dec. 2025. GuruFocus rates ASX:EMV with a GF Score™ of 24/100. The stock has 3 warning signs investors should review.

EMvision Medical Devices's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$10.46 Mil.

EMvision Medical Devices's quarterly Beginning Cash Position declined from Dec. 2024 (A$18.60 Mil) to Jun. 2025 (A$13.61 Mil) and declined from Jun. 2025 (A$13.61 Mil) to Dec. 2025 (A$10.46 Mil).

EMvision Medical Devices's annual Beginning Cash Position increased from Jun. 2023 (A$6.80 Mil) to Jun. 2024 (A$9.90 Mil) and increased from Jun. 2024 (A$9.90 Mil) to Jun. 2025 (A$18.60 Mil).

EMvision Medical Devices Beginning Cash Position Related Terms

EMvision Medical Devices Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for EMvision Medical Devices's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EMvision Medical Devices Beginning Cash Position Chart

EMvision Medical Devices Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 4.28 9.69 6.80 9.90 18.60

EMvision Medical Devices Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.97 8.41 18.60 13.61 10.46
ASX:EMV
24GF Score
EMvision Medical Devices Ltd ASX:EMV
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

EMvision Medical Devices Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$10.46 Mil mean?
EMvision Medical Devices (ASX:EMV) has a Beginning Cash Position of A$10.46 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on EMvision Medical Devices and its competitors.
Is EMvision Medical Devices' Beginning Cash Position too high?
EMvision Medical Devices' current Beginning Cash Position is A$10.46 Mil. Overall, EMvision Medical Devices has a GF Score™ of 24/100, reflecting its overall financial health beyond just this single metric.
How does EMvision Medical Devices' Beginning Cash Position compare to ABT and SYK?
EMvision Medical Devices' Beginning Cash Position of A$10.46 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on EMvision Medical Devices and its competitors. EMvision Medical Devices's current Beginning Cash Position is A$10.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EMvision Medical Devices stock overvalued right now?
EMvision Medical Devices (ASX:EMV) has a current Beginning Cash Position of A$10.46 Mil. The current Beginning Cash Position is A$10.46 Mil. EMvision Medical Devices' overall GF Score™ is 24/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For EMvision Medical Devices (ASX:EMV), the current Beginning Cash Position is A$10.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EMvision Medical Devices Business Description

Address 65 Epping Road, Suite 4.01, Macquarie Park, Sydney, NSW, AUS, 2113
EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research and development, and commercialisation of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. Its focus is portable, cost-effective, and non-invasive brain scanners, including a bedside device (emu) and an ultra-lightweight pre-hospital device (First Responder). Its first indication targets acute stroke care, with a second planned indication in traumatic brain injury.
24GF Score

Get the complete analysis for ASX:EMV

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.70
Price